Daily Papers

Drug-information question answering is a high-stakes setting where hallucinated facts can mislead clinical decision-making and the provenance of each cited fact matters as much as the fact itself. We present DrugClaw, a multi-agent retrieval-augmented system that queries a registry of drug and pharmacovigilance skills via a reflection-driven state-machine workflow and returns answers grounded in primary regulatory or peer-reviewed records. We also contribute DrugAudit, a 3,772-item authority-aware benchmark with an evaluation panel that scores upstream-of-gold source match, token-level semantic snippet overlap, and citation faithfulness under a dual-judge LLM-as-judge protocol with inter-judge kappa = 0.88 (almost-perfect). Across DrugAudit plus drug-related subsets of MedQA (751) and PubMedQA (512), DrugClaw is top-1 on every column of the headline table: composite Evidence Index under both judges, judge-mediated answer correctness, primary-source rate (0.918, +10.1 pp over next-best), faithfulness (0.887, +5.9 pp), MedQA (0.920), and PubMedQA (0.693).

Run the same LLM agent on the same task twice: do you get the same behavior? We find the answer is often no. In a study of 3,000 agent runs across three models (Llama 3.1 70B, GPT-4o, and Claude Sonnet 4.5) on HotpotQA, we observe that ReAct-style agents produce 2.0--4.2 distinct action sequences per 10 runs on average, even with identical inputs. More importantly, this variance predicts failure: tasks with consistent behavior (leq2 unique paths) achieve 80--92% accuracy, while highly inconsistent tasks (geq6 unique paths) achieve only 25--60%, a 32--55 percentage point gap depending on model. We trace variance to early decisions: 69% of divergence occurs at step 2, the first search query. Our results suggest that monitoring behavioral consistency during execution could enable early error detection and improve agent reliability.

Scaling laws are typically fit using a family of models with a narrow range of frozen hyper-parameter choices. In this work we study scaling laws using a wide range of architecture and hyper-parameter choices, and highlight their impact on resulting prescriptions. As a primary artifact of our research, we release the Gemstones: the most comprehensive open-source scaling law dataset to date, consisting of over 4000 checkpoints from transformers with up to 2 billion parameters; these models have been trained with different learning rates, cooldown schedules, and architectural shapes. Our checkpoints enable more complex studies of scaling, such as a law that predicts language modeling performance as a function of model width and depth. By examining the various facets of our model suite, we find that the prescriptions of scaling laws can be highly sensitive to the experimental design process and the specific model checkpoints used during fitting. Code: https://github.com/mcleish7/gemstone-scaling-laws

Automated environment configuration is a critical bottleneck in scaling software engineering (SWE) automation. To provide a reliable evaluation standard for this task, we present Multi-Docker-Eval benchmark. It includes 40 real-world repositories spanning 9 programming languages and measures both success in achieving executable states and efficiency under realistic constraints. Our extensive evaluation of state-of-the-art LLMs and agent frameworks reveals key insights: (1) the overall success rate of current models is low (F2P at most 37.7%), with environment construction being the primary bottleneck; (2) model size and reasoning length are not decisive factors, and open-source models like DeepSeek-V3.1 and Kimi-K2 are competitive in both efficiency and effectiveness; (3) agent framework and programming language also have significantly influence on success rate. These findings provide actionable guidelines for building scalable, fully automated SWE pipelines.

Closed-loop cooperative driving requires planners that generate realistic multimodal multi-agent trajectories while improving safety and traffic efficiency. Existing diffusion planners can model multimodal behaviors from demonstrations, but they often exhibit weak scene consistency and remain poorly aligned with closed-loop objectives; meanwhile, stable online post-training in reactive multi-agent environments remains difficult. We present Multi-ORFT, which couples scene-conditioned diffusion pre-training with stable online reinforcement post-training. In pre-training, the planner uses inter-agent self-attention, cross-attention, and AdaLN-Zero-based scene conditioning to improve scene consistency and road adherence of joint trajectories. In post-training, we formulate a two-level MDP that exposes step-wise reverse-kernel likelihoods for online optimization, and combine dense trajectory-level rewards with variance-gated group-relative policy optimization (VG-GRPO) to stabilize training. On the WOMD closed-loop benchmark, Multi-ORFT reduces collision rate from 2.04% to 1.89% and off-road rate from 1.68% to 1.36%, while increasing average speed from 8.36 to 8.61 m/s relative to the pre-trained planner, and it outperforms strong open-source baselines including SMART-large, SMART-tiny-CLSFT, and VBD on the primary safety and efficiency metrics. These results show that coupling scene-consistent denoising with stable online diffusion-policy optimization improves the reliability of closed-loop cooperative driving.

Physicians now pose millions of clinical questions to AI tools each week, yet these tools are evaluated largely on hypothetical or exam-style questions, not those actually asked in practice. We report a blinded evaluation built on 620 Real-world Point-Of-Care Queries (Real-POCQi) submitted to the OpenEvidence (OE) platform by physicians spanning 30 specialties, as well as 187 questions from HealthBench. 149 practicing physicians across 36 states made head-to-head comparisons between answers from three frontier general-purpose models (Claude Opus 4.8, Gemini 3.1 Pro, and GPT-5.5) and a specialized clinical tool (OE), with graders matched to each question's specialty. When comparing answers along five dimensions relevant to clinical decision support -- accuracy, clinical utility, source quality, verifiability, & completeness -- physicians scored the specialized tool highest on all axes; in the primary analysis on Real-POCQi, win differences (margins between win and loss rates) ranged from 25 to 39 percentage points (p<0.001). Results remained consistent in sensitivity analyses stratifying by citation display, answer length, OE-user status, and Real-POCQi versus HealthBench. In parallel, LLM judges were found to systematically differ from expert judges, though both generally agreed on the best model. These findings underscore two conclusions: (i) AI tool evaluations should reflect real-world query distributions and use expert judges that mirror the specialization defining modern medicine and (ii) the consistent advantage of the specialized tool over general-purpose models does not necessarily mean that the latter cannot serve similar purposes, but that targeted engineering and customization can yield meaningful gains in performance for its users. We release Real-POCQi as a public benchmark, as well as the prespecified statistical analysis for reproducing results of this study.